Literature DB >> 5440596

Cephaloridine serum levels in patients on maintenance haemodialysis.

J R Curtis, M J Marshall.   

Abstract

Cephaloridine serum half-life was determined in 11 patients undergoing maintenance haemodialysis. Three of them were anephric. The mean cephaloridine half-life was 10.4 hours. There was an inverse correlation between cephaloridine half-life and the duration of maintenance haemodialysis treatment. Reasons for this are discussed.The effect of haemodialysis with the Kiil dialyser on cephaloridine half-life was studied in three patients.Dosage recommendations for patients on maintenance haemodialysis are suggested.

Entities:  

Mesh：

Substances：

Year:  1970        PMID： 5440596      PMCID： PMC1699988          DOI： 10.1136/bmj.2.5702.149

Source DB:  PubMed          Journal:  Br Med J        ISSN： 0007-1447


  2 in total

1.  Cephaloridine therapy as related to renal function.

Authors:  S A Kabins; S Cohen
Journal:  Antimicrob Agents Chemother (Bethesda)       Date:  1965

2.  Excretion of cephaloridine and cephalothin in patients with renal impairment.

Authors:  C M Kunin; N Atuk
Journal:  N Engl J Med       Date:  1966-03-24       Impact factor: 91.245
  2 in total
  5 in total

Review 1.  Critical compilation of terminal half-lives, percent excreted unchanged, and changes of half-life in renal and hepatic dysfunction for studies in humans with references.

Authors:  L A Pagliaro; L Z Benet
Journal:  J Pharmacokinet Biopharm       Date:  1975-10

2.  Drug kinetics and artificial kidneys.

Authors:  T B Gibson; H A Nelson
Journal:  Clin Pharmacokinet       Date:  1977 Nov-Dec       Impact factor: 6.447

3.  Use and control of cephalosporins.

Authors:  S Eykyn
Journal:  J Clin Pathol       Date:  1971-07       Impact factor: 3.411

4.  Reversible encephalopathy and acute renal failure after cephaloridine.

Authors:  R Gabriel; R D Foord; A M Joekes
Journal:  Br Med J       Date:  1970-10-31

5.  Antibacterial agents in renal failure.

Authors: 
Journal:  Br Med J       Date:  1971-03-20
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.